Bio-Techne Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Bio-Techne Corporation's estimated annual revenue is currently $984.5M per year.
- Bio-Techne Corporation's estimated revenue per employee is $301,086
- Bio-Techne Corporation's current valuation is $15.3B. (January 2022)
Employee Data
- Bio-Techne Corporation has 3270 Employees.
- Bio-Techne Corporation grew their employee count by 0% last year.
Bio-Techne Corporation's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP | Reveal Email/Phone |
2 | VP, Cell & Gene Therapy Business Unit | Reveal Email/Phone |
3 | VP, EMEA | Reveal Email/Phone |
4 | VP, Corp Quality and Regulatory | Reveal Email/Phone |
5 | VP – Diagnostic Reagents Division | Reveal Email/Phone |
6 | SVP - Analytical Solutions Division | Reveal Email/Phone |
7 | VP – Corporate Development | Reveal Email/Phone |
8 | SVP, General Counsel & Corporate Secretary | Reveal Email/Phone |
9 | VP, Investor Relations & Corporate Development | Reveal Email/Phone |
10 | VP Human Resources | Reveal Email/Phone |
Bio-Techne Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Bio-Techne Corporation?
TECHNE Corporation (NASDAQ: TECH), incorporated in Minnesota in 1981, is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) located in Minneapolis, Minnesota and R&D Systems Europe Ltd. (RDSE) located in Abingdon, England. R&D Systems is a specialty manufacturer of biological products. It has two operating divisions: Hematology and Biotechnology. The Hematology Division develops and manufactures hematology controls, which are used in hospitals and clinical laboratories to check the accuracy of blood analysis instruments. The Biotechnology Division develops and manufactures biotechnology products including purified proteins (cytokines) and antibodies that are sold exclusively to the research market, and assay kits which are sold to the research and clinical diagnostic markets. Over 97% of TECHNE’s revenues are derived from products manufactured by R&D Systems. RDSE sells and distributes R&D Systems' biotechnology products in Europe. RDSE has a German sales subsidiary, R&D Systems GmbH. from products manufactured by R&D Systems. RDSE sells and distributes R&D Systems' biotechnology products in Europe. RDSE has a German sales subsidiary, R&D Systems GmbH.
keywords:N/A
N/A
Total Funding
3270
Number of Employees
$984.5M
Revenue (est)
0%
Employee Growth %
$15.3B
Valuation
N/A
Accelerator
Bio-Techne Corporation News
The company had revenue of $269.30 million during the quarter, compared to the consensus estimate of $266.57 million. Bio-Techne had a net...
MINNEAPOLIS, April 26, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has been included on the Forbes...
MINNEAPOLIS, April 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeSciences...
MINNEAPOLIS, Nov. 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene. The AmplideX® PCR/CE CFTR Kit, intended for research use only, provides broader coverage ...
MINNEAPOLIS, Nov. 3, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the commercial availability of GMP-grade materials manufactured at its St. Paul, MN GMP (Good Manufacturing Practices) manufacturing facility. The facility is dedicated to supporting large-scale produ ...
Other Companies in Minneapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $687.6M | 3387 | 3% | N/A |
#2 | $1557.4M | 4120 | 4% | N/A |
#3 | $2260M | 4520 | 0% | N/A |
#4 | $1920M | 5239 | 6% | N/A |
#5 | $2145.2M | 5675 | 1% | N/A |